NightHawk Biosciences Provides 2022 Year End Business Update

DURHAM, N.C., March 31, 2023 -- NightHawk Biosciences , a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided... | March 31, 2023

Related Keywords

Canada ,United States ,San Antonio ,Texas ,Kansas ,American ,Canadian ,Jeff Wolf ,Company San Antonio ,Twitter ,Nighthawk Biosciences Inc ,American Company Guidelines Sections ,Hawk Biosciences ,Chief Executive Officer ,Nighthawk Biosciences ,Company Guidelines Sections ,Private Securities Litigation Reform Act ,Nc Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,Nighthawk ,Iosciences ,Iopharmaceutical ,Company ,Ocused ,N ,Developing ,Therapies ,O ,Modulate ,The ,Immune ,Oday Nhwk Us42237k4094 ,